心脏成纤维细胞在心肌损伤与心力衰竭中的作用
该综述聚焦心脏成纤维细胞在心肌纤维化及心力衰竭中的核心作用,指出细胞外基质异常沉积损害心脏机械与电功能,而有效抗纤维化治疗仍难实现。文章强调成纤维细胞在维持组织稳态与驱动病理重塑中的动态角色,并汇总谱系追踪与单细胞组学揭示的成纤维细胞异质性,最后展望选择性调控成纤维细胞活性与机械敏感治疗的新方向。
要点
- 心脏成纤维细胞是调控心肌纤维化与心力衰竭进展的核心间质细胞。
- 谱系追踪与单细胞组学揭示心脏成纤维细胞存在多种不同状态。
- 选择性改变成纤维细胞活性及机械敏感疗法是新兴治疗方向。
核心结论
- 心脏成纤维细胞在维持心脏稳态与驱动病理重塑中均发挥动态作用,是抗纤维化治疗的关键靶点。
研究设计与样本
- 综述类文章,汇总谱系追踪模型与单细胞组学等技术在心脏成纤维细胞研究中的进展。
主要发现
- 心脏纤维化涉及细胞外基质成分异常沉积,导致心脏机械与电功能受损。
- 成纤维细胞是结构支持性但功能多样的间质细胞,调控组织架构、细胞信号与免疫反应。
- 谱系追踪与单细胞组学已识别出不同的成纤维细胞状态及其在稳态与病理重塑中的动态角色。
- 成纤维细胞参与炎症与细胞外基质失调,并与心肌细胞和内皮细胞相互作用。
临床怎么用
- 关注成纤维细胞异质性对心肌纤维化精准分型与靶向治疗的潜在价值。
- 重视成纤维细胞与心肌细胞、内皮细胞及免疫微环境的相互作用。
- 关注选择性调控成纤维细胞活性及机械敏感疗法作为新兴治疗方向。
局限性
- 有效抗纤维化治疗仍难以实现,部分源于对区分短暂与持续纤维化反应的分子细胞过程认识有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiac fibrosis is a major contributor to the development and progression of heart failure. It involves an aberrant deposition of extracellular matrix components, leading to impaired mechanical and electrical function of the heart. Despite its clinical importance, effective anti-fibrotic treatments remain elusive, in part due to limited insight into the molecular and cellular processes that distinguish transient from sustained fibrotic responses. Central to these processes are fibroblasts, structurally supportive yet functionally diverse stromal cells that regulate tissue architecture, cell signalling, and immune responses. Recent technological advances, including lineage tracing models and single-cell omics, have begun to unravel the complexity of fibroblast populations within the heart. These approaches have identified distinct fibroblast states and highlighted their dynamic roles in both maintaining homeostasis and driving pathological remodelling. This review examines the evolving understanding of fibroblast biology in the context of myocardial fibrosis, emphasizing their contributions to inflammation and extracellular matrix dysregulation and their interactions with cardiomyocytes and endothelial cells. Finally, emerging therapeutic avenues aimed at selectively altering fibroblast activity and mechanosensitive therapies are highlighted.
引用
- Van Linthout, Matz, González, et al. Cardiac fibroblasts in myocardial injury and heart failure. Eur Heart J. 2026. PMID: 41288379. doi:10.1093/eurheartj/ehaf902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。